nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—malignant glioma	0.662	1	CbGaD
Clenbuterol—CYP1A2—Carmustine—malignant glioma	0.098	1	CbGbCtD
Clenbuterol—Bambuterol—BCHE—malignant glioma	0.00329	0.618	CrCbGaD
Clenbuterol—Terbutaline—BCHE—malignant glioma	0.00203	0.382	CrCbGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR3—malignant glioma	1.95e-05	8.34e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—YWHAE—malignant glioma	1.94e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK2—malignant glioma	1.94e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FLT1—malignant glioma	1.93e-05	8.25e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DUSP6—malignant glioma	1.93e-05	8.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	1.92e-05	8.18e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CAV1—malignant glioma	1.9e-05	8.11e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAG1—malignant glioma	1.9e-05	8.11e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—YWHAE—malignant glioma	1.9e-05	8.11e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK2—malignant glioma	1.9e-05	8.11e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	1.89e-05	8.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FLT1—malignant glioma	1.89e-05	8.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	1.88e-05	8.04e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KDR—malignant glioma	1.88e-05	8.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	1.87e-05	8e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—malignant glioma	1.86e-05	7.95e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	1.86e-05	7.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAG1—malignant glioma	1.86e-05	7.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	1.85e-05	7.9e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—malignant glioma	1.84e-05	7.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	1.83e-05	7.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	1.82e-05	7.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—F2—malignant glioma	1.82e-05	7.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—F2—malignant glioma	1.81e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FN1—malignant glioma	1.81e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—malignant glioma	1.8e-05	7.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.8e-05	7.67e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BAD—malignant glioma	1.79e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	1.79e-05	7.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—F2—malignant glioma	1.78e-05	7.59e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOTCH1—malignant glioma	1.77e-05	7.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	1.75e-05	7.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	1.74e-05	7.42e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD80—malignant glioma	1.73e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.73e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CG—malignant glioma	1.73e-05	7.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APC—malignant glioma	1.73e-05	7.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	1.71e-05	7.32e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGF—malignant glioma	1.71e-05	7.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	1.71e-05	7.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	1.7e-05	7.26e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—malignant glioma	1.7e-05	7.26e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTPN11—malignant glioma	1.7e-05	7.26e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	1.7e-05	7.25e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTT1—malignant glioma	1.69e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	1.68e-05	7.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	1.67e-05	7.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KNG1—malignant glioma	1.66e-05	7.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	1.66e-05	7.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	1.65e-05	7.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—IDH2—malignant glioma	1.64e-05	6.98e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BRAF—malignant glioma	1.63e-05	6.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KNG1—malignant glioma	1.63e-05	6.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	1.59e-05	6.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS1—malignant glioma	1.58e-05	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT2—malignant glioma	1.58e-05	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	1.58e-05	6.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.58e-05	6.74e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—malignant glioma	1.58e-05	6.73e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PIK3CA—malignant glioma	1.56e-05	6.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	1.56e-05	6.65e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	1.55e-05	6.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.54e-05	6.58e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.54e-05	6.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	1.53e-05	6.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CD—malignant glioma	1.52e-05	6.5e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—malignant glioma	1.51e-05	6.45e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—malignant glioma	1.51e-05	6.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	1.5e-05	6.38e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—malignant glioma	1.49e-05	6.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—BCHE—malignant glioma	1.47e-05	6.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP3—malignant glioma	1.47e-05	6.28e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	1.47e-05	6.27e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	1.46e-05	6.23e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF2—malignant glioma	1.46e-05	6.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC5A5—malignant glioma	1.46e-05	6.21e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP3—malignant glioma	1.44e-05	6.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	1.44e-05	6.13e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	1.43e-05	6.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTK2—malignant glioma	1.42e-05	6.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	1.41e-05	6.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—IDH1—malignant glioma	1.41e-05	6e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—malignant glioma	1.4e-05	5.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HES1—malignant glioma	1.39e-05	5.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTK2—malignant glioma	1.39e-05	5.92e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	1.38e-05	5.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	1.38e-05	5.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.38e-05	5.87e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—malignant glioma	1.37e-05	5.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	1.37e-05	5.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.36e-05	5.82e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—malignant glioma	1.36e-05	5.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HES1—malignant glioma	1.36e-05	5.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SPHK1—malignant glioma	1.36e-05	5.81e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAF1—malignant glioma	1.36e-05	5.8e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	1.35e-05	5.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	1.35e-05	5.75e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2—malignant glioma	1.34e-05	5.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	1.34e-05	5.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.33e-05	5.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	1.33e-05	5.69e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CB—malignant glioma	1.33e-05	5.66e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	1.33e-05	5.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	1.32e-05	5.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	1.3e-05	5.57e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	1.3e-05	5.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—malignant glioma	1.29e-05	5.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	1.28e-05	5.47e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—malignant glioma	1.28e-05	5.45e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—malignant glioma	1.27e-05	5.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—malignant glioma	1.26e-05	5.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.26e-05	5.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	1.25e-05	5.35e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—malignant glioma	1.23e-05	5.26e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—malignant glioma	1.22e-05	5.22e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—malignant glioma	1.22e-05	5.21e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—malignant glioma	1.22e-05	5.21e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—malignant glioma	1.22e-05	5.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—malignant glioma	1.2e-05	5.11e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—malignant glioma	1.19e-05	5.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	1.19e-05	5.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.19e-05	5.08e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	1.18e-05	5.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—malignant glioma	1.17e-05	5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	1.17e-05	4.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	1.16e-05	4.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	1.16e-05	4.94e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—malignant glioma	1.15e-05	4.92e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—malignant glioma	1.15e-05	4.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.15e-05	4.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	1.14e-05	4.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAT—malignant glioma	1.14e-05	4.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CAV1—malignant glioma	1.13e-05	4.82e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—malignant glioma	1.12e-05	4.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—malignant glioma	1.12e-05	4.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.11e-05	4.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CAV1—malignant glioma	1.1e-05	4.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—malignant glioma	1.09e-05	4.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—malignant glioma	1.08e-05	4.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NCOR1—malignant glioma	1.08e-05	4.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FN1—malignant glioma	1.07e-05	4.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—F2—malignant glioma	1.07e-05	4.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BAD—malignant glioma	1.06e-05	4.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	1.05e-05	4.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—F2—malignant glioma	1.05e-05	4.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FN1—malignant glioma	1.05e-05	4.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BAD—malignant glioma	1.04e-05	4.43e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—malignant glioma	1.04e-05	4.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD80—malignant glioma	1.03e-05	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	1.03e-05	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	1.03e-05	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APC—malignant glioma	1.03e-05	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—malignant glioma	1.03e-05	4.38e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGF—malignant glioma	1.02e-05	4.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS1—malignant glioma	1.01e-05	4.31e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	1.01e-05	4.31e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD80—malignant glioma	1.01e-05	4.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.01e-05	4.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	1.01e-05	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APC—malignant glioma	1.01e-05	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGF—malignant glioma	9.94e-06	4.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	9.88e-06	4.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BRAF—malignant glioma	9.66e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—malignant glioma	9.53e-06	4.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BRAF—malignant glioma	9.45e-06	4.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT2—malignant glioma	9.4e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—BCHE—malignant glioma	9.39e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	9.36e-06	4e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—malignant glioma	9.32e-06	3.98e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.28e-06	3.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT2—malignant glioma	9.2e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	9.16e-06	3.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	9.03e-06	3.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	8.95e-06	3.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	8.84e-06	3.78e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	8.84e-06	3.77e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—malignant glioma	8.8e-06	3.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAV1—malignant glioma	8.78e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.78e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	8.75e-06	3.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.7e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	8.65e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF2—malignant glioma	8.65e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF2—malignant glioma	8.46e-06	3.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.39e-06	3.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	8.13e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—malignant glioma	8.09e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—malignant glioma	8.09e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAF1—malignant glioma	8.07e-06	3.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—malignant glioma	8e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	7.98e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	7.95e-06	3.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—malignant glioma	7.92e-06	3.38e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAF1—malignant glioma	7.89e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	7.87e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—malignant glioma	7.82e-06	3.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	7.81e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—malignant glioma	7.72e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	7.7e-06	3.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.58e-06	3.24e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	7.57e-06	3.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—malignant glioma	7.47e-06	3.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	7.4e-06	3.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	7.31e-06	3.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAT—malignant glioma	7.27e-06	3.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—malignant glioma	7.24e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—malignant glioma	7.23e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	7.15e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—malignant glioma	7.08e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—malignant glioma	7.07e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CD—malignant glioma	7.03e-06	3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NCOR1—malignant glioma	6.87e-06	2.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—malignant glioma	6.84e-06	2.92e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—malignant glioma	6.8e-06	2.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—malignant glioma	6.7e-06	2.86e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—malignant glioma	6.66e-06	2.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	6.64e-06	2.83e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—malignant glioma	6.61e-06	2.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	6.49e-06	2.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	6.15e-06	2.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CB—malignant glioma	6.13e-06	2.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—malignant glioma	6.09e-06	2.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—malignant glioma	6.07e-06	2.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	6.01e-06	2.57e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—malignant glioma	5.95e-06	2.54e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—malignant glioma	5.65e-06	2.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAV1—malignant glioma	5.6e-06	2.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—malignant glioma	5.53e-06	2.36e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—malignant glioma	5.53e-06	2.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—malignant glioma	5.41e-06	2.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.35e-06	2.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—malignant glioma	5.3e-06	2.26e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—malignant glioma	5.22e-06	2.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—malignant glioma	5.11e-06	2.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—malignant glioma	5.1e-06	2.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—malignant glioma	4.92e-06	2.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	4.8e-06	2.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	4.7e-06	2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—malignant glioma	4.64e-06	1.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—malignant glioma	4.54e-06	1.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.48e-06	1.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—malignant glioma	3.92e-06	1.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.91e-06	1.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—malignant glioma	3.87e-06	1.65e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—malignant glioma	3.84e-06	1.64e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—malignant glioma	3.74e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—malignant glioma	3.38e-06	1.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—malignant glioma	3.05e-06	1.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.38e-06	1.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—malignant glioma	1.95e-06	8.31e-06	CbGpPWpGaD
